We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$150M
AUM Growth
+$5.45M
Cap. Flow
+$901K
Cap. Flow %
0.6%
Top 10 Hldgs %
30.59%
Holding
146
New
12
Increased
34
Reduced
70
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 23.99%
2 Technology 12.59%
3 Financials 12.07%
4 Industrials 9.43%
5 Consumer Staples 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIS icon
126
General Mills
GIS
$19.4B
$222K 0.15%
4,170
WY icon
127
Weyerhaeuser
WY
$17.4B
$222K 0.15%
+6,175
New +$212K
TDTT icon
128
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
$219K 0.15%
+9,036
New +$223K
ANZ
129
DELISTED
AUSTRALIA & NW ZEAL ADS(RP5 SH
ANZ
$219K 0.15%
+8,325
New +$219K
SSB icon
130
SouthState Bank Corp
SSB
$10.2B
$211K 0.14%
+3,145
New +$193K
EPD icon
131
Enterprise Products Partners
EPD
$81.2B
$208K 0.14%
5,758
ELV icon
132
Elevance Health
ELV
$81.6B
$205K 0.14%
+1,630
New +$201K
OUTR
133
DELISTED
OUTERWALL INC
OUTR
$205K 0.14%
+2,725
New +$175K
EMF
134
Templeton Emerging Markets Fund
EMF
$314M
$171K 0.11%
+11,075
New +$187K
CLD
135
DELISTED
Cloud Peak Energy Inc
CLD
$113K 0.08%
12,300
-3,700
-23% -$41.1K
NSLR
136
Neostellar Capital Corp
NSLR
$267M
$112K 0.07%
20,021
-2,156
-10% -$13.3K
SBS icon
137
Sabesp
SBS
$19.3B
$68K 0.05%
55,433
-28,618
-34% -$40.9K
GSK icon
138
GSK
GSK
$103B
-4,460
Closed -$256K
PPLT
139
abrdn Physical Platinum Shares ETF
PPLT
$1.85B
-18,490
Closed -$234K
SLV icon
140
iShares Silver Trust
SLV
$27.7B
-10,045
Closed -$164K
KMP
141
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
-2,600
Closed -$243K

Similar funds

Roberts, Glore & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Roberts, Glore & Co held 146 positions worth $150M, up 3.8% from $144M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Roberts, Glore & Co's Q4 2014 filing shows 12 new, 34 increased, 70 reduced and 6 closed positions. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 1,476 shares worth $390K. The largest sale was Intel, an estimated $423K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q4 2014 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 1,476 shares worth $390K.
  • Roberts, Glore & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.09M increase.
  • Roberts, Glore & Co's biggest Q4 2014 reduction was Intel, cutting an estimated $423K.
  • Roberts, Glore & Co fully exited GSK in Q4 2014, selling an estimated $256K.
  • Roberts, Glore & Co's ten largest holdings make up 31% of its $150M portfolio in Q4 2014.
  • Roberts, Glore & Co opened 12 new positions and closed 6 in Q4 2014.
  • Roberts, Glore & Co's portfolio value rose 3.8% quarter-over-quarter to $150M.

Based on Roberts, Glore & Co's 13F filing for Q4 2014, filed 9 Feb 2015.